Featured Archives - Page 6 of 29 - Boston Life Sciences Times

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

December 17, 2025

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

December 16, 2025

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

December 13, 2025

THIS WEEK'S STORIES

Thermedical Treats First Patient in Pivotal Study Evaluating SERF Ablation for Life-Threatening Ventricular Tachycardia

December 16, 2025

Quantori, Expert Systems Partner to Advance Predictive AI in Drug Discovery

December 19, 2025

Nimbus Therapeutics Completes Dose Escalation in Phase 1/2 Trial of WRN Inhibitor for MSI-H Tumors

December 19, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

Most Read

Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences

PureTech Appoints Robert Lyne as Chief Executive Officer

Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs

Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders

EDITOR PICKS

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

THIS WEEK'S STORIES

Thermedical Treats First Patient in Pivotal Study Evaluating SERF Ablation for Life-Threatening Ventricular Tachycardia

Quantori, Expert Systems Partner to Advance Predictive AI in Drug Discovery

Nimbus Therapeutics Completes Dose Escalation in Phase 1/2 Trial of WRN Inhibitor for MSI-H Tumors

POPULAR CATEGORY

ABOUT US

FOLLOW US